To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system.

Summary

This bill extends the time period for new technology add-on payments, as well as for transitional pass-through payments for certain medical devices, drugs, and biologicals, under Medicare.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 December 2017

   Introduced

   Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 19 December 2017

   Introduced

   Introduced in House

   Source: IntroReferral

3. 19 December 2017

   Introduced

   Introduced in House

   Source: IntroReferral

4. 22 December 2017

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 3 January 2018

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 19 December 2017 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 19 December 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 19 December 2017

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 19 December 2017

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Reichert, David G. [R-WA-8] · R · Sponsor
• Rep. DelBene, Suzan K. [D-WA-1] · D · Sponsor
• Rep. McMorris Rodgers, Cathy [R-WA-5] · R · Sponsor
• Rep. Sewell, Terri A. [D-AL-7] · D · Sponsor
• Rep. Watson Coleman, Bonnie [D-NJ-12] · D · Sponsor
• Rep. Lance, Leonard [R-NJ-7] · R · Cosponsor
• Rep. Matsui, Doris O. [D-CA-7] · D · Cosponsor
• · hswm00 · Standing
• · hsif00 · Standing

Related records

• related to → Ensuring Equal Access to Treatments Act of 2017